As Miami continues its evolution from a seasonal party city into a true year-round cultural capital, a new venue is stepping into the spotlight with the intention of raising the bar for live music in ...

A new theory proposes that the universe’s fundamental forces and particle properties may arise from the geometry of hidden extra dimensions. These dimensions could twist and evolve over time, forming ...

Dr. Patrick Wen discussed with CURE how Modeyso treats diffuse midline glioma, and what unmet needs remain for patients now that the therapy is available. The U.S. Food and Drug Administration (FDA) ...

In the third century BCE, Apollonius of Perga asked how many circles one could draw that would touch three given circles at exactly one point each. It would take 1,800 years to prove the answer: eight ...

A massive new community is coming to Harris County, and it's planting roots right between Houston and Galveston. Brookfield Residential and CDC Houston have earmarked 1,066 acres in the booming ...

HOUSTON — Midline, a 1,000-acre community behind Baybrook Mall in southeast Houston, has a lineup of homebuilders for its first phase. Highland Homes, Perry Homes and Toll Brothers along with ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new master-planned community ...

A hidden quantum geometry that distorts electron paths has finally been observed in real materials. This “quantum metric,” once thought purely theoretical, may revolutionize electronics, ...

Credit: Jazz Pharmaceuticals. Modeyso is the first FDA-approved treatment for this rare brain tumor. Continued approval for this indication is contingent upon verification of clinical benefit in the ...

The FDA granted accelerated approval to dordaviprone (Modeyso) as the first systemic therapy for adults and children with diffuse midline glioma harboring H3 K27M mutations. Labeling stipulates use in ...

Modeyso is the first FDA-approved systemic therapy for H3 K27M-mutant diffuse midline glioma, targeting both adult and pediatric patients. Clinical trials demonstrated a 22% overall response rate with ...

Guidelines recommend against use of midline catheters for vancomycin-based outpatient parenteral antimicrobial therapy (OPAT), but evidence supporting the guidance is limited. This retrospective study ...